These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 4947805

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Dexetimide: an effective drug for the control of extrapyramidal symptoms induced by pipothiazine palmitate.
    Dom R, Van Lommel R, Baro F.
    Acta Psychiatr Scand; 1973; 49(5):563-9. PubMed ID: 4148581
    [No Abstract] [Full Text] [Related]

  • 3. Dexetimide (R 16470) in the control of neuroleptic-induced extrapyramidal side-effects. Its prophylactic value and duration of action.
    Huygens H, Vereecken JL, Tanghe A.
    Psychiatr Neurol Neurochir; 1973; 76(4):251-9. PubMed ID: 4581374
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Evaluating the long-term need for antiparkinson drugs by chronic schizophrenics.
    Klett CJ, Caffey E.
    Arch Gen Psychiatry; 1972 Apr; 26(4):374-9. PubMed ID: 4552131
    [No Abstract] [Full Text] [Related]

  • 6. Anticholinergic prophylaxis of acute haloperidol-induced acute dystonic reactions.
    Boyer WF, Bakalar NH, Lake CR.
    J Clin Psychopharmacol; 1987 Jun; 7(3):164-6. PubMed ID: 3597801
    [Abstract] [Full Text] [Related]

  • 7. Pridinolum mesylate and neuroleptic malignant syndrome.
    Giordani L, Amore M, Montanari A, Berlinzani L, Gentili C.
    Am J Psychiatry; 1985 Mar; 142(3):389-90. PubMed ID: 3970286
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Meige syndrome: relief on high-dose anticholinergic therapy.
    Duvoisin RC.
    Clin Neuropharmacol; 1983 Mar; 6(1):63-6. PubMed ID: 6850651
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Reversal of some therapeutic effects of an antipsychotic agent by an antiparkinsonism drug.
    Singh MM, Smith JM.
    J Nerv Ment Dis; 1973 Jul; 157(1):50-8. PubMed ID: 4713306
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Intravenous benzotropine mesylate challenge in acute neuroleptic-induced dystonia.
    al Jeshi A, al Kaisi HH.
    Can J Psychiatry; 1998 Feb; 43(1):85-6. PubMed ID: 9494754
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [A new synthetic antiparkinsonian drug, tropatepine hydrochloride in extrapyramidal syndromes induced by neuroleptics].
    Lambert A, dachary JM, Marie C, Oules J, Pagot R, Sales M, Vauterin C.
    Encephale; 1976 Feb; 2(2):115-21. PubMed ID: 776591
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Management of extrapyramidal side effects induced by neuroleptics.
    Tune LE, McHugh PR, Coyle JT.
    Johns Hopkins Med J; 1981 Mar; 148(3):149-53. PubMed ID: 7206408
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.